In Vivo PICX CAR-T Therapy for R/R Multiple Myeloma

Summary

This study is an investigator-initiated, single-center, single-arm clinical study with a target population of patients with relapsed or refractory multiple myeloma. It is an early exploratory clinical study evaluating the safety, tolerability, and preliminary efficacy of PICX Injection, an in vivo prepared CAR-T cell therapy, in the treatment of relapsed or refractory multiple myeloma.

Timeline

Start

2026-07-31

Primary completion

2028-04-30

Completion

2028-07-31

Drugs

Indications